Skip to main content
. 2024 Dec 18;24:1405. doi: 10.1186/s12879-024-10304-4

Table 2.

Laboratory findings at ICU admission

Total
n = 118
CMV DNAemia P
Yes
(n = 21, 17.8%)
No
(n = 97, 82.2%)
PaO2/FiO2 210 (144–286) 119 (134–270) 211 (146–287) 0.439
White blood cells (109/L) 11.6 (8.1–15.8) 9.9 (6.9–13.0) 12.1 (8.2–16.2) 0.098
Neutrophils (109/L) 9.9 (7.0–13.8) 8.7 (5.4–12.1) 10.3 (7.0–14.1) 0.109
Lymphocytes (109/L) 0.5 (0.4–0.8) 0.6 (0.3–0.8) 0.5 (0.4–0.8) 0.855
Monocytes (109/L) 0.5 (0.3–0.9) 0.3 (0.2–0.8) 0.5 (0.3–0.9) 0.130
Hemoglobin (g/L) 92 (74–112) 71 (69–91) 98 (79–112) 0.001#
 Platelet (109/L) 179 (126–265) 159 (81–265) 186 (127–262) 0.536
 Procalcitonin (ng/mL) 1.33 (0.25–8.04) 1.59 (0.64–17.22) 1.04 (0.25–6.00) 0.209
 Blood lactate (mmol/L) 1.6 (1.3–2.7) 1.8 (1.3–2.7) 1.6 (1.3–2.6) 0.744
 PT (s) 15.2 (14.3–16.4) 15.9 (14.6–16.6) 15.2 (14.2–16.3) 0.373
 APTT (s) 43.3 (37.6–51.7) 44.3 (36.1–56.6) 43.3 (37.8–51.4) 0.933
 Cardiac troponins (ng/ml) 41.6 (14.7–215.0) 54.7 (26.4–218.4) 39.3 (13.7–198.4) 0.275
 NT-proBNP (pg/mL) 1357 (445–5454) 2518 (1256–11,358) 1080 (412–4518) 0.061
AST (U/L) 38.9 (21.9–77.7) 49.2 (38.7–119.0) 35.9 (20.6–74.0) 0.046#
 Albumin (g/L) 31.5 ± 5.2 31.4 ± 5.5 31.5 ± 5.1 0.921
 T-BIL (μmol/L) 13.7 (9.8–20.2) 13.7 (10.5–20.2) 13.5 (9.8–18.9) 0.615
 Scr (μmol/L) 90.5 (63.2–169.7) 120.1 (71.0–213.7) 89.2 (63.3–147.1) 0.097
BUN (mmol/L) 10.3 (6.7–17.2) 13.2 (10.2–19.7) 10.0 (6.3–15.7) 0.047#

ICU Intensive Care Unit, CMV Cytomegalovirus, DNAemia DNA detection by quantitative polymerase chain reaction (qPCR) on peripheral blood samples, PT Prothrombin Time, APTT Activated Partial Thromboplastin Time, NT-proBNP N-terminus Precursor of B-Type Natriuretic Peptide, AST Aspartate Aminotransferase, T-BIL Total Bilirubin, Scr Serum Creatinine, BUN Serum Urea Nitrogen

#P < 0.05; Continuous variables were expressed as Mean ± SD or Median (IQRs); Bold font indicates the difference was statistically significant